Aravax



Company Announcements:
(reported by the Company)
No items found
Elevator Pitch:

Aravax is a clinical stage biotechnology company developing a novel peptide-based immunotherapy, PVX108, for the treatment of peanut allergy. Aravax is striving to improve the lives of patients living with peanut allergies by developing a therapy that precisely targets the underlying cause of disease, bringing benefits in safety and convenience.

Category: Health & biotech
URL: https://www.aravax.com.au/
Operational Status: Active
ASX Listing Code (if applicable):
Year of Commencement: 2014
Address:

Level 9, 31 Queen St, Melbourne, Victoria, 3000 Australia

State: Victoria
Overseas Operations: No
Twitter:
Facebook:
Linkedin: https://www.linkedin.com/company/aravax
Founders:
No items found
Awards won: